Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2021-07-22 Legal Proceedings Report
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(COVID-19 치료제 Lenzilumab의 식약처 임상(제1상)시험 계획(IND) 승인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Major Management Matter' (투자판단 관련 주요경영사항) disclosure. It details the approval of a Phase 1 clinical trial (IND) for a COVID-19 treatment. Since this is a specific regulatory disclosure regarding company operations and clinical trial status that does not fit into the other specialized categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2021-07-22 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Telcon RF Pharmaceutical) detailing the adjustment of conversion prices for convertible bonds (CBs). This type of disclosure is a standard regulatory requirement in the Korean market (KRX) when the conversion price of outstanding debt instruments is modified due to market price fluctuations. It falls under the category of capital structure changes and financing updates, specifically related to convertible securities.
2021-06-30 Korean
[기재정정]분기보고서 (2020.03)
Regulatory Filings Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed Quarterly Report (분기보고서). It explicitly details corrections made to financial statements (재무제표 재작성) due to errors in the valuation of financial assets. While it contains substantive financial data, it is a regulatory filing intended to correct a previously submitted periodic report, which falls under the category of Regulatory Filings (RNS) as it is a compliance-driven amendment document. Q1 2020
2021-06-18 Korean
[기재정정]반기보고서 (2020.06)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed Semi-Annual Report (반기보고서). It explicitly details corrections to financial statements (re-statement of financial data) due to errors in the valuation of financial assets. Since it contains substantive financial data and is a formal correction of a periodic financial report, it falls under the category of Interim/Quarterly Reports (IR). H1 2020
2021-06-18 Korean
[기재정정]분기보고서 (2020.09)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a Quarterly Report (분기보고서) filed by Telcon RF Pharmaceutical. It contains detailed financial statements, including consolidated and separate balance sheets and income statements, and explicitly details the reasons for the restatement of financial data. Since it provides substantive financial data and analysis for a specific interim period (Q3), it is classified as an Interim/Quarterly Report. 9M 2020
2021-06-18 Korean
[기재정정]감사보고서제출(2020사업연도)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) for an 'Audit Report Submission' (감사보고서 제출). It provides updated financial figures and audit results for the 2020 fiscal year due to accounting errors. Since it is a formal regulatory filing detailing audit-related financial data and corrections rather than the full audit report itself, it falls under the category of Audit Report / Information. FY 2020
2021-06-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.